The UCLA Center for Obesity and Metabolic health supports a number of major research programs.We offer advanced surgical and nonsurgical options for sustained weight loss and a better quality of life for you and your family. To achieve these goals, we’ve brought together a team of experienced specialists to research and treat obesity and its related conditions. The UCLA Center for Obesity and Metabolic health is an integrated research community where collaboration and interaction are fostered and prized. Scientists at the various research centers collaborate extensively with their clinical colleagues to find scientific solutions to specific obesity and metabolic health problems.
If you are a woman thinking about weight loss surgery, you may be eligible to participate in this research study. The purpose of the study is to explore the role that the brain activity -related to appetite, eating habits and food preferences- plays in weight loss after bariatric surgery and if a brain MRI could predict who will be successful in losing weight after surgery.
This study is conducted by Dr. Claudia Sanmiguel, from the UCLA Program for Ingestive Behavior and Obesity and by Drs. Erik Dutson and Yijun Chen, from the UCLA Center for Obesity and METabolic Health (COMET).
If interested, please call (310) 206-1758 or (310) 825-3287.
Protocol ID: IRB#13-001552 UCLA IRB Approved Date: 10/9/2014 through 10/8/2015 Committee: Medical IRB 3
If you are a man or woman diagnosed with obesity (BMI > 35) and non-insulin-dependent type 2 diabetes or prediabetes (either untreated or controlled with medications), you may be eligible to participate in this research study. The purpose of the study is to explore the effects of three obesity treatments – gastric bypass surgery, sleeve gastrectomy, and a very low calorie diet. The researchers will look at how each treatment influences several factors, including food preferences, taste, biological markers of obesity and diabetes, and the makeup of microorganisms that live in the human digestive tract, known as the gut microbiota. We hope to see differences in how the body’s metabolic pathways decrease weight and improve diabetes.
All study visits will take place at Cedars-Sinai Medical Center, at the Clinical & Translational Research Center (CTRC). The study is conducted by Drs. Erik Dutson and Yijun Chen, from the UCLA Center for Obesity and METabolic Health (COMET), and Drs. Stephen Pandol and Marc Goodman, from Cedars-Sinai Medical Center.
If interested, please call (310) 248-6618.
Protocol ID: IRB# 14-001692 UCLA IRB Approved Date: 2/19/15
